Nephropathy of type 1 and type 2 diabetes: Diverse pathophysiology same treatment?

Nephrology Dialysis Transplantation

Volumn 15, Issue 12, 2000, Pages 1900-1902

  Ruggenenti, Piero ^a,b   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CLINICAL TRIAL; DIABETIC NEPHROPATHY; EXERCISE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PATHOPHYSIOLOGY; PRIMARY PREVENTION; PRIORITY JOURNAL; REHABILITATION; SECONDARY PREVENTION; SMOKING CESSATION;

EID: 0033652413     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.12.1900     Document Type: Note

References (20)

1. Diabetic nephropathy
2. Nephropathy of type 2 diabetes mellitus
3. Nephropathy in patients with type 2 diabetes mellitus
4. Structural basis of diabetic nephropathy in microalbuminuric NIDDM patients: A light microscopy study
5. Heterogeneous nature of renal lesions in type 2 diabetes
6. Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy
7. Pathophysiology of progressive nephropathies
8. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade
9. Evidence that an angiotensin converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started
10. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
11. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study
12. The effect of nisoldopine as compared with enalapril on cardiovascular outcomes in patients with non insulin dependent diabetes and hypertension
13. Renoprotection in diabetes: Genetic and non-genetic risk factors and treatment
14. The effect of intensive treatment of diabetes on the development and end progression of long-term complications in insulin-dependent diabetes mellitus
15. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: A cohort study
16. Insulin lispro
17. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus
18. Prognosis of diabetic nephropathy: How to improve the outcome
19. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
20. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The steno type 2 randomised study